NYSE · CIK 0001280784
HTGC Hercules Capital, Inc.
Insider trading from SEC Form 4. Last filing 21 d ago. Close $16.51 on Oct 9, 2026, +26% from the 52-week low and -7% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Hercules Capital, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | DeAnne Aguirre director buy | $105k 5,999 shares | +80% | +8% from low-18% from high | |
| 55Moderate | Robert P Badavas director buy | $31k 1,799 shares | +42% | +8% from low-18% from high | |
| 57Moderate | Gayle A Crowell director buy | $105k 5,999 shares | +9% | +8% from low-18% from high |
Congressional trades
6 trades in HTGC disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Virginia Foxx House · R-NC | Sale | HTGC Hercules Capital, Inc. Common Stock | $50k to $100k | Jan 12 / Feb 6 25 days after the trade | Clerk |
Virginia Foxx House · R-NC | Purchase | HTGC Hercules Capital, Inc. Common Stock | $1,001 to $15k | Nov 19, 2025 / Dec 1, 2025 12 days after the trade | Clerk |
Virginia Foxx House · R-NC | Partial sale | HTGC Hercules Capital, Inc. Common Stock | $15k to $50k | Sep 25, 2025 / Oct 6, 2025 11 days after the trade | Clerk |
Virginia Foxx House · R-NC | Purchase | HTGC Hercules Capital, Inc. Common Stock | $1,001 to $15k | Aug 19, 2025 / Sep 8, 2025 20 days after the trade | Clerk |
Virginia Foxx House · R-NC | Purchase | HTGC Hercules Capital, Inc. Common Stock | $1,001 to $15k | May 20, 2025 / Jun 3, 2025 14 days after the trade | Clerk |
Virginia Foxx House · R-NC | Purchase | HTGC Hercules Capital, Inc. Common Stock | $1,001 to $15k | Mar 5, 2025 / Apr 4, 2025 30 days after the trade | Clerk |
Transactions
The last 39 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Alfred Fichera director | AGrant or award Common Stock | +3,483 | $17.76 | $62k | 3,483 | 21 d ago |
| Sep 9, 2026 | Seth H Meyer President | FTax withholding Common Stock | -5 | $17.61 | $88 | 435,600 | 31 d ago |
| Jun 18, 2025 | DeAnne Aguirre director | AGrant or award Common Stock | +3,329 | $18.02 | $60k | 11,021 | Jun 20, 2025 |
| Jun 18, 2025 | DeAnne Aguirre director | DDisposition to issuer Common Stock | -5,999 | $0.00 | $0 | 5,067 | Jun 20, 2025 |
| Jun 18, 2025 | DeAnne Aguirre director | AGrant or award Common Stockindirect: By Trust | +5,999 | $0.00 | $0 | 18,180 | Jun 20, 2025 |
| May 8, 2025 | DeAnne Aguirre director | POpen-market purchase Common Stock | +5,999 | $17.49 | $105k | 13,529 | May 9, 2025 |
| May 8, 2025 | Robert P Badavas director | POpen-market purchase Common Stock | +1,799 | $17.49 | $31k | 6,033 | May 9, 2025 |
| May 8, 2025 | Gayle A Crowell director | POpen-market purchase Common Stock | +5,999 | $17.49 | $105k | 69,344 | May 9, 2025 |
| May 8, 2025 | DeAnne Aguirre director | DDisposition to issuer Common Stock | -5,837 | $0.00 | $0 | 7,692 | May 9, 2025 |
| May 8, 2025 | Robert P Badavas director | DDisposition to issuer Common Stock | -1,411 | $0.00 | $0 | 4,622 | May 9, 2025 |
| May 8, 2025 | DeAnne Aguirre director | DDisposition to issuer Common Stockindirect: By Trust | +5,837 | $0.00 | $0 | 12,181 | May 9, 2025 |
| May 8, 2025 | Robert P Badavas director | AGrant or award Common Stockindirect: By Trust | +1,411 | $0.00 | $0 | 108,863 | May 9, 2025 |
| Apr 11, 2025 | Scott Bluestein Chief Executive Officer | FTax withholding Common Stock | -13,307 | $16.83 | $224k | 2,292,204 | Apr 15, 2025 |
| Apr 11, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -788 | $16.83 | $13k | 67,563 | Apr 15, 2025 |
| Apr 9, 2025 | Scott Bluestein Chief Executive Officer | FTax withholding Common Stock | -10,370 | $17.49 | $181k | 2,305,511 | Apr 11, 2025 |
| Apr 9, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -843 | $17.49 | $15k | 68,351 | Apr 11, 2025 |
| Jan 10, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -213 | $19.73 | $4,202 | 70,013 | Jan 14, 2025 |
| Jan 11, 2025 | Seth H Meyer Chief Financial Officer | FTax withholding Common Stock | -7,721 | $19.73 | $152k | 393,083 | Jan 14, 2025 |
| Jan 11, 2025 | Scott Bluestein Chief Executive Officer | FTax withholding Common Stock | -22,006 | $19.73 | $434k | 2,315,881 | Jan 14, 2025 |
| Jan 11, 2025 | Christian Follmann Chief Operating Officer | FTax withholding Common Stock | -1,256 | $19.73 | $25k | 122,505 | Jan 14, 2025 |
| Jan 11, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -819 | $19.73 | $16k | 69,194 | Jan 14, 2025 |
| Jan 9, 2025 | Scott Bluestein Chief Executive Officer | FTax withholding Common Stock | -43,034 | $19.98 | $860k | 2,096,145 | Jan 13, 2025 |
| Jan 9, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -4,295 | $19.98 | $86k | 42,698 | Jan 13, 2025 |
| Jan 9, 2025 | Seth H Meyer Chief Financial Officer | FTax withholding Common Stock | -16,351 | $19.98 | $327k | 318,221 | Jan 13, 2025 |
| Jan 9, 2025 | Christian Follmann Chief Operating Officer | FTax withholding Common Stock | -4,266 | $19.98 | $85k | 89,977 | Jan 13, 2025 |
| Jan 9, 2025 | Seth H Meyer Chief Financial Officer | AGrant or award Common Stock | +82,583 | $19.98 | $1.7M | 400,804 | Jan 13, 2025 |
| Jan 9, 2025 | Christian Follmann Chief Operating Officer | AGrant or award Common Stock | +33,784 | $19.98 | $675k | 123,761 | Jan 13, 2025 |
| Jan 9, 2025 | Kiersten Zaza Botelho Chief Legal Officer & CCO | AGrant or award Common Stock | +27,528 | $19.98 | $550k | 70,226 | Jan 13, 2025 |
| Jan 9, 2025 | Scott Bluestein Chief Executive Officer | AGrant or award Common Stock | +241,742 | $19.98 | $4.8M | 2,337,887 | Jan 13, 2025 |
| Dec 5, 2024 | Scott Bluestein Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +33,051 | $0.00 | $0 | 147,198 | Dec 9, 2024 |
| Dec 5, 2024 | Kiersten Zaza Botelho Chief Legal Officer & CCO | AGrant or award Restricted Stock Unitsderivative | +10,576 | $0.00 | $0 | 23,775 | Dec 9, 2024 |
| Dec 5, 2024 | Christian Follmann Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +10,576 | $0.00 | $0 | 28,888 | Dec 9, 2024 |
| Dec 5, 2024 | Seth H Meyer Chief Financial Officer | AGrant or award Common Stock | +132 | $18.91 | $2,496 | 334,572 | Dec 9, 2024 |
| Dec 5, 2024 | Seth H Meyer Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +10,576 | $0.00 | $0 | 37,264 | Dec 9, 2024 |
| Oct 11, 2024 | Scott Bluestein Chief Executive Officer | FTax withholding Common Stock | -22,027 | $19.63 | $432k | 2,139,179 | Oct 15, 2024 |
| Oct 11, 2024 | Christian Follmann Chief Operating Officer | FTax withholding Common Stock | -1,251 | $19.63 | $25k | 94,008 | Oct 15, 2024 |
| Oct 11, 2024 | Seth H Meyer Chief Financial Officer | FTax withholding Common Stock | -7,770 | $19.63 | $153k | 334,440 | Oct 15, 2024 |
| Oct 10, 2024 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -213 | $19.74 | $4,205 | 47,796 | Oct 15, 2024 |
| Oct 11, 2024 | Kiersten Zaza Botelho Chief Legal Officer & CCO | FTax withholding Common Stock | -803 | $19.63 | $16k | 46,993 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- DeAnne Aguirredirector
- Robert P Badavasdirector
- Scott BluesteinChief Executive Officer
- Kiersten Zaza BotelhoChief Legal Officer & CCO
- Gayle A Crowelldirector
- Alfred Ficheradirector
- Christian FollmannChief Operating Officer
- Seth H MeyerPresident
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.